Comparison of hemostatic powders and surgicel on behind bladder bleeding during hysterectomy

Comparison of short-term complications of hemostatic powders and surgicel on retrovesical bleeding during hysterectomy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200316046787N1

Enrollment

Registered

2020-03-24

Start date

2020-03-20

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hysterectomy. Other noninflammatory disorders of uterus, except cervix

Interventions

Intervention 1: Intervention grou 1:Surgicel and cauter are used topically during bleeding. All drugs are manufactured by Johanson & Johanson Company. Intervention 2: Intervention group2: ChitoHem and

Eligibility

Sex/Gender

Female

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patient candidate for elective abdominal hysterectomy Age range 40-70 years

Exclusion criteria

Exclusion criteria: Need to have surgery again Need to get blood and its products pregnancy and taking OCP history of systemic diseases history of inherited or acquired coagulation disorders history of ischemic heart disease history of taking anticoagulants and effective on bleeding smoking and alcohol drinking

Design outcomes

Primary

Measure	Time frame
Hematocrit. Timepoint: 12 hours after surgery. Method of measurement: Complete blood count test (CBC).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLobat Jfarzadeh

Shahre-kord University of Medical Sciences

jafarzade@skums.ac.ir+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026